SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011934
Filing Date
2018-05-08
Accepted
2018-05-08 17:16:53
Documents
59
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-10q_20180331.htm 10-Q 1518383
2 EX-10.1 ovid-ex101_66.htm EX-10.1 157772
3 EX-10.2 ovid-ex102_121.htm EX-10.2 157793
4 EX-31.1 ovid-ex311_8.htm EX-31.1 21241
5 EX-31.2 ovid-ex312_7.htm EX-31.2 21492
6 EX-32.1 ovid-ex321_6.htm EX-32.1 7531
  Complete submission text file 0001564590-18-011934.txt   5263077

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ovid-20180331.xml EX-101.INS 1000359
8 XBRL TAXONOMY EXTENSION SCHEMA ovid-20180331.xsd EX-101.SCH 36879
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovid-20180331_cal.xml EX-101.CAL 31898
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovid-20180331_def.xml EX-101.DEF 114524
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovid-20180331_lab.xml EX-101.LAB 278266
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovid-20180331_pre.xml EX-101.PRE 215497
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 18815791
SIC: 2834 Pharmaceutical Preparations